Clinical and Experimental Reproductive Medicine

  • 제31권2호
  • /
  • Pages.83-94
  • /
  • 2004
  • /
  • 2233-8233(pISSN)
  • /
  • 2233-8241(eISSN)
대한생식의학회 (The Korean Society for Reproductive Medicine)
권호 표지

GnRH-agonist에 의한 인간 과립-황체화 세포의 세포사멸과 PBR 단백질의 발현

Apoptosis and Peripheral Benzodiazepin Receptor (PBR) Expression in Human Granulosa-Luteal Cells by GnRH-agonist

  • 김세광 (연세대학교 의과대학 산부인과학교실) ;
  • 염윤희 (한양대학교 자연과학대학 생명과학과) ;
  • 윤정미 (연세대학교 의과대학 산부인과학교실) ;
  • 배상욱 (연세대학교 의과대학 산부인과학교실) ;
  • 양현원 (을지의과대학교 생명과학연구소) ;
  • 조동제 (연세대학교 의과대학 산부인과학교실) ;
  • 윤용달 (한양대학교 자연과학대학 생명과학과) ;
  • 송찬호 (연세대학교 의과대학 산부인과학교실)
  • Kim, Sei-Kwang (Department of Obstetrics and Gynecology, College of Medicine, Yonsei University) ;
  • Youm, Yun-Hee (Department of Life Sciences, College of Natural Sciences, Hanyang University) ;
  • Yoon, Jeong-Mi (Department of Obstetrics and Gynecology, College of Medicine, Yonsei University) ;
  • Bai, Sang-Wook (Department of Obstetrics and Gynecology, College of Medicine, Yonsei University) ;
  • Yang, Hyun-Won (Life Science Institute, Eulji University School of Medicine) ;
  • Cho, Dong-Jae (Department of Obstetrics and Gynecology, College of Medicine, Yonsei University) ;
  • Yoon, Yong-Dal (Department of Life Sciences, College of Natural Sciences, Hanyang University) ;
  • Song, Chan-Ho (Department of Obstetrics and Gynecology, College of Medicine, Yonsei University)
  • 발행 : 2004.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objective: To investigate whether GnRH-agonist (GnRH-Ag) using in IVF-ET affects apoptosis of human granulosa-luteal cells and expression of peripheral benzodiazepine receptor (PBR) protein involved in the apoptosis of the cells. Methods: Granulosa-luteal cells obtained during oocyte retrieval were cultured and treated with $10^{-5}M$ GnRH-Ag. Apoptosis of the cells by the treatment was confirmed using DNA fragmentation analysis 24 h after culture. The presence of PBR protein within the cells was examined by immunofluorescence staining and the expression of the protein was analyzed by Western blotting. In addition, it was measured for progesterone and nitric oxide (NO) produced by granulosa-luteal cells after GnRH-Ag treatment. To evaluate the relationship between NO production and PBR expression, sodium nitroprusside (SNP) as a NO donor was added in media and investigated the expression of PBR protein by Western blotting. Results: Apoptosis increased in the granulosa-luteal cells 24 h after GnRH-Ag treatment, whereas the expression of PBR protein significantly decreased. Furthermore, the production of progesterone and nitric oxide (NO) by the cells significantly fell from 12 h after the treatment. In the results of Western blotting after SNP treatment, the expression of PBR protein increased in the treatment with SNP alone to the granulosa-luteal cells, but was suppressed in the treatment with GnRH-Ag and SNP. Additionally, the staining result of PBR protein in the cells showed the even distribution of it through the cell. Conclusion: These results demonstrate that GnRH-Ag treatment induces apoptosis, decreasing expression of PBR protein and NO production in human granulosa-luteal cells. The present study suggests that one of the apoptosis mechanism of human granulosa-luteal cells by GnRH-Ag might be a signal transduction pathway via NO and PBR.

키워드

참고문헌

  1. Barbieri RL, Hornstein MD. Assisted reproduction-in vitro fertilization success is improved by ovarian stimulation with exogenous gonadotropins and pituitary suppression with gonadotropin-releasing hormone analogues. Endocr Rev 1999; 20: 249-52 https://doi.org/10.1210/er.20.3.249
  2. Beckers NG, Macklon NS, Eijkemans MJ, Ludwig M, Felberbaum RE, Diedrich K, et al. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment. J Clin Endocrinol Metab 2003; 88: 4186-92 https://doi.org/10.1210/jc.2002-021953
  3. Peng C, Fan NC, Ligier M, Vaananen J, Leung PC. Expression and regulation of gonadotropin-releasing hormone (GnRH) and GnRH receptor messenger ribonucleic acids in human granulosa-luteal cells. Endocrinology 1994; 135: 1740-6 https://doi.org/10.1210/en.135.5.1740
  4. Minaretzis D, Jakubowski M, Mortola JF, Pavlou SN. Gonadotropin-releasing hormone receptor gene expression in human ovary and granulosa-lutein cells. J Clin Endocrinol Metab 1995; 80: 430-4 https://doi.org/10.1210/jc.80.2.430
  5. Erickson GF, Magoffin DA, Dyer CA, Hofeditz C. The ovarian androgen producing cells: a review of structure function relationships. Endocr Rev 1985; 6: 371-99 https://doi.org/10.1210/edrv-6-3-371
  6. Rippel RH, Johnson ES. Inhibition of hCG-induced ovarian and uterine weight augmentation in the immature rat by analogs of GnRH. Proc Soc Exp Biol Med 1976; 152: 432-6 https://doi.org/10.3181/00379727-152-39413
  7. Bicsak TA, Tucker EM, Cappel S, Vaugham V, Rivier J, Vale W, et al. Hormonal regulation of granulosa cell inhibin biosyuthesis. Endocrinology 1986; 114: 2711-9
  8. Parborell F, Dain L, Tesone M. Gonadotropin-releasing hormone agonist affects rat ovarian follicle development by interfering with FSH and growth factors on the prevention of apoptosis. Mol Reprod Dev 2001; 60: 241-7 https://doi.org/10.1002/mrd.1084
  9. Takekida S, Matsuo H, Maruo T. GnRH agonist action on granulosa cells at varying follicular stages. Mol Cell Endocrinol 2003; 202: 155-64 https://doi.org/10.1016/S0303-7207(03)00077-7
  10. Erickson GF, Li D, Sadrkhanloo R, Liu XJ, Shimasaki S, Ling N. Extrapituitary actions of gonadotropin-releasing hormone: stimulation of insulin-like growth factor-binding protein-4 and aterisa. Endocrinology 1994; 134: 1365-72 https://doi.org/10.1210/en.134.3.1365
  11. Sridaran R, Hisheh S, Dharmarajan AM. Induction of apoptosis by a gonadotropin-releasing hormone agonist during early pregnancy in the rat. Apoptosis 1998; 3: 51-7 https://doi.org/10.1023/A:1009611203705
  12. Sridaran R, Lee MA, Haynes L, Srivastava RK, Ghose M, Sridaran G, et al. GnRH action on luteal steroidogenesis during pregnancy. Steroids 1999; 64: 618-23 https://doi.org/10.1016/S0039-128X(99)00042-2
  13. Papadopoulos V, Amri H, Boujrad N, Cascio C, Culty M, Garnier M, et al. Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis. Steroids 1997; 62: 21-8 https://doi.org/10.1016/S0039-128X(96)00154-7
  14. Papadopoulos V, Dharmarajan AM, Li H, Culty M, Lemay M, Sridaran R. Mitochondrial peripheral-type benzodiazepine receptor expression: correlation with gonadotropin-releasing hormone (GnRH) agonistinduced apoptosis in the corpus luteum. Biochem Pharmacol 1999; 58: 1389-93 https://doi.org/10.1016/S0006-2952(99)00215-4
  15. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-42
  16. Hesla JS, Preutthipan S, Maguire MP, Chang TS, Wallach EE, Dharmarajan AM. Nitric oxide modulates human chorionic gonadotropin-induced ovulation in the rabbit. Fertil Steril 1997; 67: 548-52 https://doi.org/10.1016/S0015-0282(97)80084-2
  17. Jablonka-Shariff A, Olson LM. The role of nitric oxide in oocyte meiotic maturation and ovulation: meiotic abnormalities of endothelial nitric oxide synthase knock-out mouse oocytes. Endocrinology 1998; 139: 2944-54 https://doi.org/10.1210/en.139.6.2944
  18. Van Voorhis BJ, Dunn MS, Snyder GD, Weiner CP. Nitric oxide: an autocrine regulator of human granulosa-luteal cell steroidogenesis. Endocrinology 1994; 135: 1799-806 https://doi.org/10.1210/en.135.5.1799
  19. Dixit VD, Parvizi N. Nitiric oxide and the control of reproduction. Anim Reprod Sci 2001; 65: 1-16 https://doi.org/10.1016/S0378-4320(00)00224-4
  20. Shukovski L, Tsafriri A. The involvement of nitric oxide in the ovulatory process in the rat. Endocrinology 1994; 135: 2287-90 https://doi.org/10.1210/en.135.5.2287
  21. Jablonka A, Olson LM. The role of nitric oxide in oocyte meiotic maturation and ovulation: meiotic abnormalities of endothelial nitric oxide synthase knock-out mouse oocytes. Endocrinology 1998; 139: 2944-54 https://doi.org/10.1210/en.139.6.2944
  22. Olson LM, Jones-Burton CM, Jablonka-Shariff A. Nitric oxide decreases estradiol synthesis in rat luteal cells in vitro: possible role for nitric oxide in functional luteal regression. Endocrinology 1996; 137: 3531-39 https://doi.org/10.1210/en.137.8.3531
  23. Smith CJ, Richards JS, Yasin K, Sangster JN, Sridaran R. Changes in rat luteal ultrastructure and P450scc mRNA and protein content after in vivo treatment with a gonadotropin-releasing hormone agonist. Biol Reprod 1991; 44: 382-91 https://doi.org/10.1095/biolreprod44.2.382
  24. Nelson SE, McLean MP, Jayatilak PG, Gibori G. Isolation, characterization, and culture of cell subpopulations forming the pregnant rat corpus luteum. Endocrinology 1992; 130: 954-66 https://doi.org/10.1210/en.130.2.954
  25. Pellicer A, Tarin JJ, Miro F, Sampaio M, De los Santos MJ, Remohi J. The use of gonadotrophin releasing-hormone analogues (GnRHa), in in-vitro fertilization: some clinical and experimental investigations of a direct effect on the human ovary. Hum Reprod 1992; 7 Suppl 1: 39-47.32
  26. Herman A, Ron-El R, Golan A, Raziel A, Soffer Y, Caspi E. Pregnancy rate and ovarian hyperstimulation after luteal human chorionic gonadotropin in in vitro fertilization stimulated with gonadotropinreleasing hormone analog and menotropins. Fertil Steril 1990; 53: 92-6 https://doi.org/10.1016/S0015-0282(16)53222-1
  27. Billig H, Furuta I, Hsueh AJW. Gonadotropin-releasing hormone (GnRH) directly induces apoptotic cell death in the rat ovary: biochemical and in situ detection of deoxyribonucleic acid fragmentation in granulosa cells. Endocrinology 1994; 134: 245-52 https://doi.org/10.1210/en.134.1.245
  28. Peng C, Fan NC, Ligier M, Vaananen J, Leung PCK Expression and regulation of gonadotropin-releasing hormone (GnRH) and GnRH receptor messenger ribonucleic acids in human granulosa luteal cells. Endocrinology 1994; 135: 1740-6
  29. Chun SY, Eisenhauer KM, Kubo M, Hsueh AJW. Interleukin-1$\beta$ suppresses apoptosis in rat ovarian follicles by increasing nitric oxide production. Endocrinology 1995; 136: 3120-7. https://doi.org/10.1210/en.136.7.3120
  30. Kim YM, Bombeck CA, Billiar TR. Nitric oxide as a bifunctional regulator of apoptosis. Circ Res 1999; 84: 253-6 https://doi.org/10.1161/01.RES.84.3.253
  31. Basini G, Baratta M, Ponderato N, Bussolati S, Tamanini C. Is nitric oxide an autocrine modulator of bovine granulosa cell function? Reprod Fertil Dev 1998; 10: 471-8
  32. Yang H, Bhat GK, Wadley R, Wright KL, Chung BM, Whittaker JA, et al. Gonadotropin-releasing hormone-agonist inhibits synthesis of nitric oxide and steroidogenesis by luteal cells in the pregnant rat. Biol Reprod 2003; 68: 2222-31 https://doi.org/10.1095/biolreprod.102.011635
  33. Matsumi H, Koji T, Yano T, Yano N, Tsutsumi O, Momoeda M, et al. Evidence for an inverse relationship between apoptosis and inducible nitric oxide synthesis expression in rat granulosa cells: a possible role of nitric oxide in ovarian follicle atresia. Endocr J 1998; 45: 745-51 https://doi.org/10.1507/endocrj.45.745
  34. Chun SY, Eisenhauer KM, Minami S, Billig H, Perlas E, Hsueh AJW. Hormonal regulation of apoptosis in early antral follicle: follicle-stimulating hormone as a major survival factor. Endocrinology 1996; 137: 1447-56 https://doi.org/10.1210/en.137.4.1447
  35. Gavish M, Bachmann I, Shoukrun R, Katz Y, Veenman L, Weisinger G, et al. Enigma of the peripheral benzodiazepine receptor. Pharmacol Rev 1999; 51: 629-50
  36. McEnery MW, Snowman AM, Trifiletti RR, Snyder SH. Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine dinucleotide carrier. Proc Natl Acad Sci USA 1992; 89: 3170-4 https://doi.org/10.1073/pnas.89.8.3170
  37. Bono F, Lamarche I, Prabonnaud V, Le Fur G, Herbert JM, Peripheral benzodiazepine receptor agonists exhibit potent anti-apoptotic activities. Biochem Biophys Res Commun 1999; 265: 457-61 https://doi.org/10.1006/bbrc.1999.1683
  38. Susin SA, Zamzami N, Kroemer G. Mitochondria as regulators of apoptosis: doubt no more. Biochim Biophys Acta 1998; 1366: 151-65 https://doi.org/10.1016/S0005-2728(98)00110-8
  39. Fennell DA, Corbo M, Pallaska A, Cotter FE. Bcl-2 resistant mitochondrial toxicity mediated by the isoquinoline carboxamide PK 11195 involves de novo generation of reactive oxygen species. Br J Cancer 2001; 84: 1397-404 https://doi.org/10.1054/bjoc.2001.1788
  40. Xia W, Spector S, Hardy L, Zhao S, Saluk A, Alemane L, et al. Tumor selective G2/M cell cycle arrest and apoptosis of epithelial and hematological malignancies by BBL22 a benzazepine. Proc Natl Acad Sci USA 2000; 97: 7494-9 https://doi.org/10.1073/pnas.97.13.7494